Business
Press Release Jun 27 2025
Biocon Limited has informed the Exchange regarding a press release dated Jun 27, 2025, titled "Biocon Biologics Receives Health Canada Approval for Yesafili (aflibercept); First Global Launch Scheduled for July 2025".
About this update from Biocon Limited
[{"type":"text","content":" Biocon Limited has informed the Exchange regarding a press release dated Jun 27, 2025, titled \"Biocon Biologics Receives Health Canada Approval for Yesafili (aflibercept); First Global Launch Scheduled for July 2025\". View Attachment","length":370,"tagName":"div"}]